Earlier this year, JosÉ Baselga, MD, the physician-in-chief and chief medical officer at Memorial Sloan Kettering Cancer Center in New York City, resigned after failing to report millions of dollars in payments from drug and device companies.
According to the federal Open Payments database, Dr. Baselga had received close to $3.5 million from Genentech and other drugmakers from August 2013 through 2017. But, as The New York Times and ProPublica found, he did not disclose those financial ties in the majority of his research papers.
